Details for New Drug Application (NDA): 217593
✉ Email this page to a colleague
NDA 217593 describes QAMZOVA, which is a drug marketed by Nanjing Delova and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the QAMZOVA profile page.
The generic ingredient in QAMZOVA is meloxicam. There are twenty-two drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the meloxicam profile page.
The generic ingredient in QAMZOVA is meloxicam. There are twenty-two drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the meloxicam profile page.
Summary for 217593
| Tradename: | QAMZOVA |
| Applicant: | Nanjing Delova |
| Ingredient: | meloxicam |
| Patents: | 1 |
Pharmacology for NDA: 217593
| Mechanism of Action | Cyclooxygenase Inhibitors |
Suppliers and Packaging for NDA: 217593
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| QAMZOVA | meloxicam | SOLUTION;INTRAVENOUS | 217593 | NDA | Nanjing Delova Biotech Co., Ltd. | 82972-001 | 82972-001-30 | 1 VIAL, SINGLE-DOSE in 1 CARTON (82972-001-30) / 1 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 30MG/ML (30MG/ML) | ||||
| Approval Date: | Apr 22, 2025 | TE: | RLD: | Yes | |||||
| Patent: | ⤷ Get Started Free | Patent Expiration: | Jul 19, 2040 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
Complete Access Available with Subscription
